<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.8.26">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>19&nbsp; Drug Discovery &amp; Biotech – Genomic Foundation Models</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for citations */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
  margin-bottom: 0em;
}
.hanging-indent div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./references.html" rel="next">
<link href="./ch-p5-variants.html" rel="prev">
<script src="site_libs/quarto-html/quarto.js" type="module"></script>
<script src="site_libs/quarto-html/tabsets/tabsets.js" type="module"></script>
<script src="site_libs/quarto-html/axe/axe-check.js" type="module"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting-587c61ba64f3a5504c4d52d930310e48.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap-a1553387a0f784068632030e9fbb8a3c.min.css" rel="stylesheet" append-hash="true" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 50,
  "keyboard-shortcut": [
    "f",
    "/",
    "s"
  ],
  "show-item-context": false,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-text-placeholder": "",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit",
    "search-label": "Search"
  }
}</script>


<link rel="stylesheet" href="styles.css">
</head>

<body class="nav-sidebar floating quarto-light">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav">
    <div class="container-fluid d-flex">
      <button type="button" class="quarto-btn-toggle btn" data-bs-toggle="collapse" role="button" data-bs-target=".quarto-sidebar-collapse-item" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
        <i class="bi bi-layout-text-sidebar-reverse"></i>
      </button>
        <nav class="quarto-page-breadcrumbs" aria-label="breadcrumb"><ol class="breadcrumb"><li class="breadcrumb-item"><a href="./ch-p5-clinical.html">Part V: Applications</a></li><li class="breadcrumb-item"><a href="./ch-p5-drugs.html"><span class="chapter-number">19</span>&nbsp; <span class="chapter-title">Drug Discovery &amp; Biotech</span></a></li></ol></nav>
        <a class="flex-grow-1" role="navigation" data-bs-toggle="collapse" data-bs-target=".quarto-sidebar-collapse-item" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">      
        </a>
      <button type="button" class="btn quarto-search-button" aria-label="Search" onclick="window.quartoOpenSearch();">
        <i class="bi bi-search"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse collapse-horizontal quarto-sidebar-collapse-item sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="./">Genomic Foundation Models</a> 
    </div>
      </div>
        <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
        </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Introduction</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./preface.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Preface</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" role="navigation" aria-expanded="true">
 <span class="menu-text">Part I: Data &amp; Pre-DL Methods</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" role="navigation" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p1-ngs.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">NGS &amp; Variant Calling</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p1-prs.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">PRS &amp; GWAS Basics</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p1-cadd.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Deleteriousness Scores</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p1-data.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Foundational Genomics Data</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-2" role="navigation" aria-expanded="true">
 <span class="menu-text">Part II: CNN Seq-to-Function Models</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-2" role="navigation" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-2" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p2-reg.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Regulatory Prediction</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p2-transc.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Transcriptional Effects</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p2-splice.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Splicing Prediction</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-3" role="navigation" aria-expanded="true">
 <span class="menu-text">Part III: Transformers Models</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-3" role="navigation" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-3" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p3-tokens.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Sequence Representation &amp; Tokens</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p3-plm.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Protein Language Models</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p3-glm.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">DNA Foundation Models</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p3-hybrid.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">11</span>&nbsp; <span class="chapter-title">Long-range Hybrid Models</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-4" role="navigation" aria-expanded="true">
 <span class="menu-text">Part IV: GFMs &amp; Multi-omics</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-4" role="navigation" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-4" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p4-principles.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">12</span>&nbsp; <span class="chapter-title">Genomic FMs: Principles &amp; Practice</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p4-vep.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">13</span>&nbsp; <span class="chapter-title">Variant Effect Prediction</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p4-omics.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">14</span>&nbsp; <span class="chapter-title">Multi-omics and Systems Context</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p4-confound.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">15</span>&nbsp; <span class="chapter-title">Confounders in Model Training</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p4-interp.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">16</span>&nbsp; <span class="chapter-title">Interpretability &amp; Mechanisms</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-5" role="navigation" aria-expanded="true">
 <span class="menu-text">Part V: Applications</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-5" role="navigation" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-5" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p5-clinical.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">17</span>&nbsp; <span class="chapter-title">Clinical Risk Prediction</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p5-variants.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">18</span>&nbsp; <span class="chapter-title">Pathogenic Variant Discovery</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ch-p5-drugs.html" class="sidebar-item-text sidebar-link active">
 <span class="menu-text"><span class="chapter-number">19</span>&nbsp; <span class="chapter-title">Drug Discovery &amp; Biotech</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./references.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">References</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-6" role="navigation" aria-expanded="true">
 <span class="menu-text">Appendices</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-6" role="navigation" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-6" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./app-dl.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">A</span>&nbsp; <span class="chapter-title">Deep Learning Primer for Genomics</span></span></a>
  </div>
</li>
      </ul>
  </li>
    </ul>
    </div>
</nav>
<div id="quarto-sidebar-glass" class="quarto-sidebar-collapse-item" data-bs-toggle="collapse" data-bs-target=".quarto-sidebar-collapse-item"></div>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#where-genomics-touches-the-drug-discovery-pipeline" id="toc-where-genomics-touches-the-drug-discovery-pipeline" class="nav-link active" data-scroll-target="#where-genomics-touches-the-drug-discovery-pipeline"><span class="header-section-number">19.1</span> Where Genomics Touches the Drug Discovery Pipeline</a></li>
  <li><a href="#target-discovery-and-genetic-validation" id="toc-target-discovery-and-genetic-validation" class="nav-link" data-scroll-target="#target-discovery-and-genetic-validation"><span class="header-section-number">19.2</span> Target Discovery and Genetic Validation</a>
  <ul class="collapse">
  <li><a href="#from-variant-level-scores-to-gene-level-targets" id="toc-from-variant-level-scores-to-gene-level-targets" class="nav-link" data-scroll-target="#from-variant-level-scores-to-gene-level-targets"><span class="header-section-number">19.2.1</span> From variant-level scores to gene-level targets</a></li>
  <li><a href="#linking-genetic-evidence-to-target-safety-and-efficacy" id="toc-linking-genetic-evidence-to-target-safety-and-efficacy" class="nav-link" data-scroll-target="#linking-genetic-evidence-to-target-safety-and-efficacy"><span class="header-section-number">19.2.2</span> Linking genetic evidence to target safety and efficacy</a></li>
  <li><a href="#evolving-from-hand-curated-to-model-centric-target-triage" id="toc-evolving-from-hand-curated-to-model-centric-target-triage" class="nav-link" data-scroll-target="#evolving-from-hand-curated-to-model-centric-target-triage"><span class="header-section-number">19.2.3</span> Evolving from hand-curated to model-centric target triage</a></li>
  </ul></li>
  <li><a href="#functional-genomics-screens-in-drug-discovery" id="toc-functional-genomics-screens-in-drug-discovery" class="nav-link" data-scroll-target="#functional-genomics-screens-in-drug-discovery"><span class="header-section-number">19.3</span> Functional Genomics Screens in Drug Discovery</a>
  <ul class="collapse">
  <li><a href="#designing-smarter-perturbation-libraries" id="toc-designing-smarter-perturbation-libraries" class="nav-link" data-scroll-target="#designing-smarter-perturbation-libraries"><span class="header-section-number">19.3.1</span> Designing smarter perturbation libraries</a></li>
  <li><a href="#interpreting-screen-readouts-with-gfms" id="toc-interpreting-screen-readouts-with-gfms" class="nav-link" data-scroll-target="#interpreting-screen-readouts-with-gfms"><span class="header-section-number">19.3.2</span> Interpreting screen readouts with GFMs</a></li>
  </ul></li>
  <li><a href="#biomarker-discovery-patient-stratification-and-trial-design" id="toc-biomarker-discovery-patient-stratification-and-trial-design" class="nav-link" data-scroll-target="#biomarker-discovery-patient-stratification-and-trial-design"><span class="header-section-number">19.4</span> Biomarker Discovery, Patient Stratification, and Trial Design</a>
  <ul class="collapse">
  <li><a href="#from-polygenic-risk-scores-to-gfm-informed-biomarkers" id="toc-from-polygenic-risk-scores-to-gfm-informed-biomarkers" class="nav-link" data-scroll-target="#from-polygenic-risk-scores-to-gfm-informed-biomarkers"><span class="header-section-number">19.4.1</span> From polygenic risk scores to GFM-informed biomarkers</a></li>
  <li><a href="#multi-omic-and-single-cell-biomarker-discovery" id="toc-multi-omic-and-single-cell-biomarker-discovery" class="nav-link" data-scroll-target="#multi-omic-and-single-cell-biomarker-discovery"><span class="header-section-number">19.4.2</span> Multi-omic and single-cell biomarker discovery</a></li>
  </ul></li>
  <li><a href="#biotech-workflows-and-infrastructure-for-gfms" id="toc-biotech-workflows-and-infrastructure-for-gfms" class="nav-link" data-scroll-target="#biotech-workflows-and-infrastructure-for-gfms"><span class="header-section-number">19.5</span> Biotech Workflows and Infrastructure for GFMs</a>
  <ul class="collapse">
  <li><a href="#gfms-as-shared-infrastructure" id="toc-gfms-as-shared-infrastructure" class="nav-link" data-scroll-target="#gfms-as-shared-infrastructure"><span class="header-section-number">19.5.1</span> GFMs as shared infrastructure</a></li>
  <li><a href="#build-vs-buy-vs-fine-tune" id="toc-build-vs-buy-vs-fine-tune" class="nav-link" data-scroll-target="#build-vs-buy-vs-fine-tune"><span class="header-section-number">19.5.2</span> Build vs buy vs fine-tune</a></li>
  <li><a href="#ip-collaboration-and-regulatory-considerations" id="toc-ip-collaboration-and-regulatory-considerations" class="nav-link" data-scroll-target="#ip-collaboration-and-regulatory-considerations"><span class="header-section-number">19.5.3</span> IP, collaboration, and regulatory considerations</a></li>
  </ul></li>
  <li><a href="#forward-look-toward-lab-in-the-loop-gfms" id="toc-forward-look-toward-lab-in-the-loop-gfms" class="nav-link" data-scroll-target="#forward-look-toward-lab-in-the-loop-gfms"><span class="header-section-number">19.6</span> Forward Look: Toward Lab-in-the-Loop GFMs</a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default"><nav class="quarto-page-breadcrumbs quarto-title-breadcrumbs d-none d-lg-block" aria-label="breadcrumb"><ol class="breadcrumb"><li class="breadcrumb-item"><a href="./ch-p5-clinical.html">Part V: Applications</a></li><li class="breadcrumb-item"><a href="./ch-p5-drugs.html"><span class="chapter-number">19</span>&nbsp; <span class="chapter-title">Drug Discovery &amp; Biotech</span></a></li></ol></nav>
<div class="quarto-title">
<h1 class="title"><span class="chapter-number">19</span>&nbsp; <span class="chapter-title">Drug Discovery &amp; Biotech</span></h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  


</header>


<p>Genomic foundation models (GFMs) are built to turn raw sequence and multi-omic data into <em>reusable biological representations</em> and <em>fine-grained predictions</em> (Chapter 12). In previous chapters you saw how these models improve variant effect prediction (Chapters 10, 11, 13), long-range regulatory modeling (Chapters 8, 11, 12), and disease genetics workflows (Chapters 14–16).</p>
<p>This chapter zooms out to ask a more translational question:</p>
<blockquote class="blockquote">
<p>How do genomic foundation models actually plug into <strong>drug discovery and biotech workflows</strong>?</p>
</blockquote>
<p>Rather than walking step-by-step through a single therapeutic program, this chapter offers a compact, high-level map of where GFMs are already useful—or plausibly soon will be. The focus is on three broad roles:</p>
<ol type="1">
<li><p><strong>Target discovery and genetic validation</strong>:<br>
Using human genetics, variant-level scores, and gene-level evidence to prioritize safer, more effective targets.</p></li>
<li><p><strong>Functional genomics and perturbation screens</strong>:<br>
Designing, interpreting, and iteratively improving large-scale CRISPR/perturb-seq/MPRA screens with help from GFMs.</p></li>
<li><p><strong>Biomarkers, patient stratification, and biotech infrastructure</strong>:<br>
Turning model outputs into biomarkers for trial design and integrating GFMs into the industrial MLOps stack.</p></li>
</ol>
<p>Throughout, the aim is not to promise “end-to-end AI drug discovery,” but to show pragmatic ways that genomic foundation models can <strong>reduce risk, prioritize hypotheses, and make experiments more informative</strong>, especially when coupled to high-quality human data.</p>
<hr>
<section id="where-genomics-touches-the-drug-discovery-pipeline" class="level2" data-number="19.1">
<h2 data-number="19.1" class="anchored" data-anchor-id="where-genomics-touches-the-drug-discovery-pipeline"><span class="header-section-number">19.1</span> Where Genomics Touches the Drug Discovery Pipeline</h2>
<p>The canonical small-molecule or biologics pipeline is often summarized as:</p>
<ol type="1">
<li><strong>Target identification and validation</strong><br>
</li>
<li><strong>Hit finding and lead optimization</strong><br>
</li>
<li><strong>Preclinical characterization (safety, PK/PD, tox)</strong><br>
</li>
<li><strong>Clinical trials (Phase I–III) and post-marketing</strong></li>
</ol>
<p>Genomics most directly enters at three points:</p>
<ul>
<li><strong>Early-stage target discovery and validation</strong>
<ul>
<li>Human genetic associations (GWAS, rare-variant burden, somatic mutation landscapes) point to potential targets.<br>
</li>
<li>Variant-level effect predictions and gene-level constraint metrics help de-prioritize potentially unsafe or non-causal signals.</li>
</ul></li>
<li><strong>Biomarker discovery and patient stratification</strong>
<ul>
<li>Genetic risk scores, regulatory embeddings, and multi-omic signatures define patient subgroups and endpoints for trials.<br>
</li>
<li>Embeddings from GFMs make it easier to find <em>molecularly coherent</em> patient strata beyond traditional clinical labels.</li>
</ul></li>
<li><strong>Mechanism-of-action (MoA) and resistance</strong>
<ul>
<li>Functional genomics screens and perturbation assays help dissect how a compound perturbs cellular networks.<br>
</li>
<li>GFMs can predict which perturbations matter and suggest follow-up experiments.</li>
</ul></li>
</ul>
<p>Other AI-for-drug-discovery efforts focus on molecular design, docking, or protein structure; those are largely beyond the scope of this book. Here we stay close to the <strong>DNA- and RNA-centric</strong> capabilities you’ve seen earlier: variant effect prediction, regulatory modeling, and multi-omics integration.</p>
<hr>
</section>
<section id="target-discovery-and-genetic-validation" class="level2" data-number="19.2">
<h2 data-number="19.2" class="anchored" data-anchor-id="target-discovery-and-genetic-validation"><span class="header-section-number">19.2</span> Target Discovery and Genetic Validation</h2>
<p>Human genetics provides some of the strongest evidence that modulating a particular target can safely change disease risk. GFMs don’t replace classical statistical genetics, but they provide <em>richer priors</em> and <em>more mechanistic features</em> for identifying and validating targets.</p>
<section id="from-variant-level-scores-to-gene-level-targets" class="level3" data-number="19.2.1">
<h3 data-number="19.2.1" class="anchored" data-anchor-id="from-variant-level-scores-to-gene-level-targets"><span class="header-section-number">19.2.1</span> From variant-level scores to gene-level targets</h3>
<p>Variant effect prediction (VEP) models provide a natural starting point. Earlier chapters introduced:</p>
<ul>
<li><strong>Genome-wide deleteriousness scores</strong> such as CADD, which integrate diverse annotations and—more recently—deep and foundation-model features <span class="citation" data-cites="rentzsch_cadd_2019 schubach_cadd_2024">(<a href="references.html#ref-rentzsch_cadd_2019" role="doc-biblioref">Rentzsch et al. 2019</a>; <a href="references.html#ref-schubach_cadd_2024" role="doc-biblioref">Schubach et al. 2024</a>)</span>.</li>
<li><strong>Protein-centric VEP GFMs</strong>, including AlphaMissense, GPN-MSA, and AlphaGenome, which combine protein language models, structure, and long-range context to score coding variants <span class="citation" data-cites="cheng_alphamissense_2023 benegas_gpn-msa_2024 avsec_alphagenome_2025 brandes_genome-wide_2023">(<a href="references.html#ref-cheng_alphamissense_2023" role="doc-biblioref">Cheng et al. 2023</a>; <a href="references.html#ref-benegas_gpn-msa_2024" role="doc-biblioref">Benegas, Albors, et al. 2024</a>; <a href="references.html#ref-avsec_alphagenome_2025" role="doc-biblioref">Z. Avsec, Latysheva, and Cheng 2025</a>; <a href="references.html#ref-brandes_genome-wide_2023" role="doc-biblioref">Brandes et al. 2023</a>)</span>.</li>
<li><strong>Sequence-to-function models</strong> such as Enformer and long-context DNA LMs (e.g., Nucleic Transformer, HyenaDNA), which predict regulatory outputs from large genomic windows <span class="citation" data-cites="avsec_enformer_2021 he_nucleic_2023 nguyen_hyenadna_2023 trop_genomics_2024">(<a href="references.html#ref-avsec_enformer_2021" role="doc-biblioref">Ž. Avsec et al. 2021</a>; <a href="references.html#ref-he_nucleic_2023" role="doc-biblioref">He et al. 2023</a>; <a href="references.html#ref-nguyen_hyenadna_2023" role="doc-biblioref">Nguyen et al. 2023</a>; <a href="references.html#ref-trop_genomics_2024" role="doc-biblioref">Trop et al. 2024</a>)</span>.</li>
</ul>
<p>Drug target teams rarely care about <em>individual variants</em> per se; they care about <strong>genes and pathways</strong>. The key move is therefore to aggregate variant-level information into <strong>gene-level evidence</strong>:</p>
<ul>
<li><strong>Coding variant aggregation</strong>
<ul>
<li>Summarize missense and predicted loss-of-function (pLoF) variants in each gene using VEP scores.<br>
</li>
<li>Partition variants by predicted functional category (e.g.&nbsp;likely loss-of-function vs.&nbsp;benign missense) and by allele frequency.<br>
</li>
<li>Derive gene-level metrics such as “burden of predicted damaging variants in cases vs controls.”</li>
</ul></li>
<li><strong>Noncoding and regulatory evidence</strong>
<ul>
<li>Aggregate variant effect predictions on enhancers, promoters, and splice sites that link (via chromatin interaction maps or models like Enformer) to a candidate gene <span class="citation" data-cites="avsec_enformer_2021 he_nucleic_2023">(<a href="references.html#ref-avsec_enformer_2021" role="doc-biblioref">Ž. Avsec et al. 2021</a>; <a href="references.html#ref-he_nucleic_2023" role="doc-biblioref">He et al. 2023</a>)</span>.<br>
</li>
<li>Use long-range GFMs to connect distal regulatory elements to target loci across 100 kb–1 Mb.</li>
</ul></li>
<li><strong>Constraint and intolerance</strong>
<ul>
<li>Combine VEP-informed burden with gene constraint measures (as used implicitly in CADD and downstream tools) to identify genes that are highly intolerant to damaging variation <span class="citation" data-cites="rentzsch_cadd_2019 schubach_cadd_2024">(<a href="references.html#ref-rentzsch_cadd_2019" role="doc-biblioref">Rentzsch et al. 2019</a>; <a href="references.html#ref-schubach_cadd_2024" role="doc-biblioref">Schubach et al. 2024</a>)</span>.<br>
</li>
<li>Extremely constrained genes may be risky targets (essentiality/toxicity), while “dose-sensitive” but not lethal genes may present more attractive opportunities.</li>
</ul></li>
</ul>
<p>From a GFM perspective, the core idea is to <strong>treat gene-level evidence as an aggregation problem over high-dimensional variant embeddings</strong>. Instead of manually defining a handful of summary statistics, teams can feed variant embeddings or predicted functional profiles into downstream models that learn which patterns matter most for disease.</p>
</section>
<section id="linking-genetic-evidence-to-target-safety-and-efficacy" class="level3" data-number="19.2.2">
<h3 data-number="19.2.2" class="anchored" data-anchor-id="linking-genetic-evidence-to-target-safety-and-efficacy"><span class="header-section-number">19.2.2</span> Linking genetic evidence to target safety and efficacy</h3>
<p>Classical human genetics has established several now-standard heuristics for target selection:</p>
<ul>
<li><strong>“Human knockout” individuals</strong> (carrying biallelic LoF variants) provide a natural experiment on what happens when a gene is effectively inactivated.<br>
</li>
<li><strong>Protective variants</strong> that reduce disease risk suggest <em>directionality</em> of effect (e.g.&nbsp;partial inhibition of a protein is beneficial rather than harmful).<br>
</li>
<li><strong>Pleiotropy</strong>—associations with many unrelated traits—may signal safety liabilities.</li>
</ul>
<p>GFMs reinforce and extend these ideas by:</p>
<ul>
<li><strong>Improving causal variant identification</strong>
<ul>
<li>Fine-mapping methods and multiple-instance models like MIFM can distinguish truly causal regulatory variants from correlated passengers <span class="citation" data-cites="wu_genome-wide_2024 rakowski_mifm_2025">(<a href="references.html#ref-wu_genome-wide_2024" role="doc-biblioref">Wu et al. 2024</a>; <a href="references.html#ref-rakowski_mifm_2025" role="doc-biblioref">Rakowski and Lippert 2025</a>)</span>.<br>
</li>
<li>Combining these with regulatory GFMs tightens the map from GWAS locus → variant → target gene.</li>
</ul></li>
<li><strong>Refining effect direction and magnitude</strong>
<ul>
<li>VEP scores from protein and regulatory GFMs can approximate effect sizes (e.g.&nbsp;how “severe” a missense change is, or how strongly a regulatory variant alters expression) <span class="citation" data-cites="cheng_alphamissense_2023 benegas_gpn-msa_2024 avsec_alphagenome_2025">(<a href="references.html#ref-cheng_alphamissense_2023" role="doc-biblioref">Cheng et al. 2023</a>; <a href="references.html#ref-benegas_gpn-msa_2024" role="doc-biblioref">Benegas, Albors, et al. 2024</a>; <a href="references.html#ref-avsec_alphagenome_2025" role="doc-biblioref">Z. Avsec, Latysheva, and Cheng 2025</a>)</span>.<br>
</li>
<li>This can help differentiate subtle modulators from catastrophic LoF.</li>
</ul></li>
<li><strong>Highlighting mechanism-enriched loci</strong>
<ul>
<li>GFMs provide multi-task predictions (chromatin marks, TF binding, expression, splicing) that make it easier to interpret <em>how</em> a risk locus affects biology <span class="citation" data-cites="avsec_enformer_2021 benegas_genomic_2024">(<a href="references.html#ref-avsec_enformer_2021" role="doc-biblioref">Ž. Avsec et al. 2021</a>; <a href="references.html#ref-benegas_genomic_2024" role="doc-biblioref">Benegas, Ye, et al. 2024</a>)</span>.</li>
</ul></li>
</ul>
<p>In practice, a target discovery workflow might:</p>
<ol type="1">
<li>Start from GWAS summary statistics or rare variant analyses.<br>
</li>
<li>Apply fine-mapping (e.g.&nbsp;MIFM) to identify candidate causal variants <span class="citation" data-cites="wu_genome-wide_2024 rakowski_mifm_2025">(<a href="references.html#ref-wu_genome-wide_2024" role="doc-biblioref">Wu et al. 2024</a>; <a href="references.html#ref-rakowski_mifm_2025" role="doc-biblioref">Rakowski and Lippert 2025</a>)</span>.<br>
</li>
<li>Score candidate variants with VEP GFMs (both protein and regulatory).<br>
</li>
<li>Map variants to genes using long-range regulatory models (Enformer, Nucleic Transformer, HyenaDNA) <span class="citation" data-cites="avsec_enformer_2021 he_nucleic_2023 nguyen_hyenadna_2023">(<a href="references.html#ref-avsec_enformer_2021" role="doc-biblioref">Ž. Avsec et al. 2021</a>; <a href="references.html#ref-he_nucleic_2023" role="doc-biblioref">He et al. 2023</a>; <a href="references.html#ref-nguyen_hyenadna_2023" role="doc-biblioref">Nguyen et al. 2023</a>)</span>.<br>
</li>
<li>Aggregate signals into gene-level “genetic support” scores, incorporating constraint and pleiotropy information.</li>
</ol>
<p>The result is a <strong>ranked list of candidate targets</strong> with structured evidence that can be compared across diseases and programs.</p>
</section>
<section id="evolving-from-hand-curated-to-model-centric-target-triage" class="level3" data-number="19.2.3">
<h3 data-number="19.2.3" class="anchored" data-anchor-id="evolving-from-hand-curated-to-model-centric-target-triage"><span class="header-section-number">19.2.3</span> Evolving from hand-curated to model-centric target triage</h3>
<p>Historically, target triage relied heavily on <em>manual curation</em>:</p>
<ul>
<li>Experts would review GWAS hits, literature, and pathway diagrams.<br>
</li>
<li>Limited quantitative information was available for most genes, especially in non-classical pathways.</li>
</ul>
<p>GFMs shift this towards a <strong>model-centric, continuously updated view</strong>:</p>
<ul>
<li>New data (e.g.&nbsp;biobank sequencing, single-cell atlases) can be fed through trained GFMs to update variant and gene evidence.<br>
</li>
<li>The same underlying model suite can support many disease programs, enabling consistent cross-portfolio comparisons.<br>
</li>
<li>Benchmark frameworks like TraitGym emphasize standardized evaluation of genotype-phenotype modeling, helping teams choose appropriate model stacks for a given trait <span class="citation" data-cites="benegas_traitgym_2025">(<a href="references.html#ref-benegas_traitgym_2025" role="doc-biblioref">Benegas, Eraslan, and Song 2025</a>)</span>.</li>
</ul>
<p>The limiting factor becomes less “do we have an annotation?” and more “can we interpret the model’s representation and connect it to biological plausibility and druggability?”—a theme echoed in Chapters 13 and 15.</p>
<hr>
</section>
</section>
<section id="functional-genomics-screens-in-drug-discovery" class="level2" data-number="19.3">
<h2 data-number="19.3" class="anchored" data-anchor-id="functional-genomics-screens-in-drug-discovery"><span class="header-section-number">19.3</span> Functional Genomics Screens in Drug Discovery</h2>
<p>While human genetics offers <em>observational</em> evidence, drug discovery also relies heavily on <strong>perturbation experiments</strong>:</p>
<ul>
<li>CRISPR knockout/knockdown/activation screens.<br>
</li>
<li>Base-editing or saturation mutagenesis around key domains.<br>
</li>
<li>MPRA and massively parallel promoter/enhancer assays.<br>
</li>
<li>Perturb-seq and other high-throughput transcriptomic readouts.</li>
</ul>
<p>Genomic foundation models are well positioned to both <strong>design</strong> and <strong>interpret</strong> such screens.</p>
<section id="designing-smarter-perturbation-libraries" class="level3" data-number="19.3.1">
<h3 data-number="19.3.1" class="anchored" data-anchor-id="designing-smarter-perturbation-libraries"><span class="header-section-number">19.3.1</span> Designing smarter perturbation libraries</h3>
<p>Traditional pooled screens often rely on simple design rules (e.g.&nbsp;one sgRNA per exon, or tiling a region at fixed spacing). GFMs enable more <em>information-dense</em> designs:</p>
<ul>
<li><strong>Sequence-to-function priors</strong>
<ul>
<li>Models like DeepSEA, Enformer, and related CNN/transformer architectures predict which bases are most functionally critical for regulatory outputs <span class="citation" data-cites="zhou_deepsea_2015 avsec_enformer_2021 benegas_genomic_2024">(<a href="references.html#ref-zhou_deepsea_2015" role="doc-biblioref">Zhou and Troyanskaya 2015</a>; <a href="references.html#ref-avsec_enformer_2021" role="doc-biblioref">Ž. Avsec et al. 2021</a>; <a href="references.html#ref-benegas_genomic_2024" role="doc-biblioref">Benegas, Ye, et al. 2024</a>)</span>.<br>
</li>
<li>Library design can focus perturbations on high-sensitivity sites—predicted TF motifs, splice junctions, or enhancer “hotspots.”</li>
</ul></li>
<li><strong>Variant prioritization for saturation mutagenesis</strong>
<ul>
<li>Protein and DNA GFMs can prioritize substitutions expected to span a wide range of predicted fitness, enabling better estimation of quantitative genotype–phenotype maps <span class="citation" data-cites="cheng_alphamissense_2023 marquet_vespag_2024">(<a href="references.html#ref-cheng_alphamissense_2023" role="doc-biblioref">Cheng et al. 2023</a>; <a href="references.html#ref-marquet_vespag_2024" role="doc-biblioref">Marquet et al. 2024</a>)</span>.<br>
</li>
<li>This is especially useful for deep mutational scanning near active sites or in regulatory domains.</li>
</ul></li>
<li><strong>Off-target and safety considerations</strong>
<ul>
<li>Sequence models can help filter sgRNA designs with high predicted off-target binding, or prioritize guide positions that minimize unintended regulatory disruption.</li>
</ul></li>
</ul>
<p>The overarching idea is to <strong>maximize the information gained per experimental budget</strong> by letting GFMs suggest <em>where</em> to perturb in sequence space.</p>
</section>
<section id="interpreting-screen-readouts-with-gfms" class="level3" data-number="19.3.2">
<h3 data-number="19.3.2" class="anchored" data-anchor-id="interpreting-screen-readouts-with-gfms"><span class="header-section-number">19.3.2</span> Interpreting screen readouts with GFMs</h3>
<p>Once a screen has been run, GFMs can assist in several ways:</p>
<ul>
<li><strong>Embedding perturbations and outcomes</strong>
<ul>
<li>Encode each perturbed sequence (e.g.&nbsp;enhancer variant, gene knockout) using a DNA or protein GFM, and represent each experimental condition as the combination of its embedding and observed phenotype (e.g.&nbsp;expression profile).<br>
</li>
<li>This enables manifold learning over perturbations, in which clusters correspond to shared mechanism-of-action.</li>
</ul></li>
<li><strong>Mapping hits back to pathways</strong>
<ul>
<li>Combine GFMs with graph-based models over protein–protein interaction networks and regulatory networks to identify enriched pathways <span class="citation" data-cites="gao_high-ppi_2023 yuan_linger_2025">(<a href="references.html#ref-gao_high-ppi_2023" role="doc-biblioref">Gao et al. 2023</a>; <a href="references.html#ref-yuan_linger_2025" role="doc-biblioref">Yuan and Duren 2025</a>)</span>.<br>
</li>
<li>Learned embeddings help propagate signal to weakly observed genes or variants.</li>
</ul></li>
<li><strong>Closing the loop with model retraining</strong>
<ul>
<li>Use screen outcomes as labeled examples to fine-tune sequence-to-function models in the relevant cell type or context.<br>
</li>
<li>This “lab-in-the-loop” refinement turns generic GFMs into highly tuned models for the cell system of interest.</li>
</ul></li>
</ul>
<p>For example, an MPRA that assays thousands of enhancer variants can yield sequence–activity pairs that dramatically improve expression-prediction GFMs in that locus or tissue. Conversely, model predictions can suggest follow-up experiments (additional variants, cell types, or perturbation strengths) that would be maximally informative given previous data.</p>
<hr>
</section>
</section>
<section id="biomarker-discovery-patient-stratification-and-trial-design" class="level2" data-number="19.4">
<h2 data-number="19.4" class="anchored" data-anchor-id="biomarker-discovery-patient-stratification-and-trial-design"><span class="header-section-number">19.4</span> Biomarker Discovery, Patient Stratification, and Trial Design</h2>
<p>Even when a target is well validated, many programs fail in late-stage trials because <strong>the right patients, endpoints, or biomarkers were not selected</strong>. GFMs, combined with large cohorts, offer new tools for defining and validating biomarkers.</p>
<section id="from-polygenic-risk-scores-to-gfm-informed-biomarkers" class="level3" data-number="19.4.1">
<h3 data-number="19.4.1" class="anchored" data-anchor-id="from-polygenic-risk-scores-to-gfm-informed-biomarkers"><span class="header-section-number">19.4.1</span> From polygenic risk scores to GFM-informed biomarkers</h3>
<p>Classical <strong>polygenic risk scores (PRS)</strong> summarize the additive effect of many common variants on disease risk. Deep learning methods such as Delphi extend this idea by learning non-linear genotype–phenotype mappings directly from genome-wide data <span class="citation" data-cites="georgantas_delphi_2024">(<a href="references.html#ref-georgantas_delphi_2024" role="doc-biblioref">Georgantas, Kutalik, and Richiardi 2024</a>)</span>.</p>
<p>GFMs can enhance these approaches by:</p>
<ul>
<li><strong>Providing richer genetic features</strong>
<ul>
<li>Instead of raw genotypes, models can use VEP-derived scores, variant embeddings, or gene-level features produced by GFMs.<br>
</li>
<li>This can capture non-additive effects, regulatory architecture, and variant-level biology in a more compact representation.</li>
</ul></li>
<li><strong>Transferring knowledge across traits and ancestries</strong>
<ul>
<li>Foundation models trained across diverse genomes (e.g.&nbsp;Nucleotide Transformer, GENA-LM, HyenaDNA) provide features that may generalize more robustly across populations than trait-specific models <span class="citation" data-cites="dalla-torre_nucleotide_2023 fishman_gena-lm_2025 nguyen_hyenadna_2023">(<a href="references.html#ref-dalla-torre_nucleotide_2023" role="doc-biblioref">Dalla-Torre et al. 2023</a>; <a href="references.html#ref-fishman_gena-lm_2025" role="doc-biblioref">Fishman et al. 2025</a>; <a href="references.html#ref-nguyen_hyenadna_2023" role="doc-biblioref">Nguyen et al. 2023</a>)</span>.<br>
</li>
<li>Fine-mapping–aware approaches like MIFM further reduce dependence on linkage disequilibrium patterns <span class="citation" data-cites="wu_genome-wide_2024 rakowski_mifm_2025">(<a href="references.html#ref-wu_genome-wide_2024" role="doc-biblioref">Wu et al. 2024</a>; <a href="references.html#ref-rakowski_mifm_2025" role="doc-biblioref">Rakowski and Lippert 2025</a>)</span>.</li>
</ul></li>
<li><strong>Distinguishing risk and progression</strong>
<ul>
<li>By integrating regulatory and expression predictions, risk models can differentiate genetic influences on <em>disease onset</em> vs <em>progression</em>, enabling more targeted enrichment strategies.</li>
</ul></li>
</ul>
<p>In trial design, such models can be used to:</p>
<ul>
<li>Enrich for high-risk individuals (in prevention trials).<br>
</li>
<li>Define genetic subtypes that may respond differently to the same mechanism.<br>
</li>
<li>Construct composite biomarkers that mix genetics with conventional clinical features.</li>
</ul>
</section>
<section id="multi-omic-and-single-cell-biomarker-discovery" class="level3" data-number="19.4.2">
<h3 data-number="19.4.2" class="anchored" data-anchor-id="multi-omic-and-single-cell-biomarker-discovery"><span class="header-section-number">19.4.2</span> Multi-omic and single-cell biomarker discovery</h3>
<p>Beyond DNA variation, drug development increasingly leverages <strong>multi-omic and single-cell readouts</strong>:</p>
<ul>
<li>Whole-genome/exome tumor sequencing combined with expression, methylation, and copy-number profiling.<br>
</li>
<li>Single-cell multiome datasets (RNA + ATAC) that characterize cell-state landscapes in disease <span class="citation" data-cites="jurenaite_setquence_2024 yuan_linger_2025">(<a href="references.html#ref-jurenaite_setquence_2024" role="doc-biblioref">Jurenaite et al. 2024</a>; <a href="references.html#ref-yuan_linger_2025" role="doc-biblioref">Yuan and Duren 2025</a>)</span>.<br>
</li>
<li>Microbiome sequencing for host–microbe interplay and response to therapy <span class="citation" data-cites="yan_recent_2025">(<a href="references.html#ref-yan_recent_2025" role="doc-biblioref">Yan et al. 2025</a>)</span>.</li>
</ul>
<p>GFMs and related architectures can help here in several ways:</p>
<ul>
<li><strong>Set-based and graph-based encoders</strong>
<ul>
<li>Models like SetQuence/SetOmic treat heterogeneous genomic features for each tumor as a set, using deep set transformers to extract predictive representations <span class="citation" data-cites="jurenaite_setquence_2024">(<a href="references.html#ref-jurenaite_setquence_2024" role="doc-biblioref">Jurenaite et al. 2024</a>)</span>.<br>
</li>
<li>GRN inference models such as LINGER leverage atlas-scale multiome data to infer regulatory networks that can serve as biomarkers of pathway activity <span class="citation" data-cites="yuan_linger_2025">(<a href="references.html#ref-yuan_linger_2025" role="doc-biblioref">Yuan and Duren 2025</a>)</span>.</li>
</ul></li>
<li><strong>Multi-scale integration</strong>
<ul>
<li>DNA and RNA GFMs can be combined with graph neural networks over gene and protein networks to build end-to-end predictors that map from genotype + cell state to clinical endpoints <span class="citation" data-cites="gao_high-ppi_2023 benegas_genomic_2024">(<a href="references.html#ref-gao_high-ppi_2023" role="doc-biblioref">Gao et al. 2023</a>; <a href="references.html#ref-benegas_genomic_2024" role="doc-biblioref">Benegas, Ye, et al. 2024</a>)</span>.<br>
</li>
<li>Embeddings from protein LMs (e.g.&nbsp;ESM-2-based variant models) provide additional structure for coding variants <span class="citation" data-cites="brandes_genome-wide_2023 marquet_vespag_2024">(<a href="references.html#ref-brandes_genome-wide_2023" role="doc-biblioref">Brandes et al. 2023</a>; <a href="references.html#ref-marquet_vespag_2024" role="doc-biblioref">Marquet et al. 2024</a>)</span>.</li>
</ul></li>
<li><strong>Biomarker discovery workflows</strong>
<ul>
<li>Use GFMs to generate rich embeddings for patients (e.g.&nbsp;from tumor genomes, germline variation, or multi-omic profiles).<br>
</li>
<li>Cluster or perform supervised learning to identify molecular subgroups with differential prognosis or treatment response.<br>
</li>
<li>Validate candidate biomarkers on held-out cohorts or external datasets before deploying them in a trial.</li>
</ul></li>
</ul>
<p>The key shift is that biomarkers are no longer limited to a handful of hand-picked variants or expression markers: they become <strong>functions over high-dimensional genomic and multi-omic embeddings</strong>, learned in a data-driven way yet grounded in biological priors from GFMs.</p>
<hr>
</section>
</section>
<section id="biotech-workflows-and-infrastructure-for-gfms" class="level2" data-number="19.5">
<h2 data-number="19.5" class="anchored" data-anchor-id="biotech-workflows-and-infrastructure-for-gfms"><span class="header-section-number">19.5</span> Biotech Workflows and Infrastructure for GFMs</h2>
<p>For pharma and biotech organizations, the primary challenge is not “can we train a big model?” so much as <strong>“how do we integrate GFMs into existing data platforms, governance, and decision-making?”</strong></p>
<section id="gfms-as-shared-infrastructure" class="level3" data-number="19.5.1">
<h3 data-number="19.5.1" class="anchored" data-anchor-id="gfms-as-shared-infrastructure"><span class="header-section-number">19.5.1</span> GFMs as shared infrastructure</h3>
<p>In a mature organization, GFMs should be treated as <strong>shared infrastructure</strong>, not ad hoc scripts:</p>
<ul>
<li><strong>Model catalog</strong>
<ul>
<li>DNA LMs (e.g.&nbsp;Nucleic Transformer, HyenaDNA, GENA-LM) <span class="citation" data-cites="he_nucleic_2023 nguyen_hyenadna_2023 fishman_gena-lm_2025">(<a href="references.html#ref-he_nucleic_2023" role="doc-biblioref">He et al. 2023</a>; <a href="references.html#ref-nguyen_hyenadna_2023" role="doc-biblioref">Nguyen et al. 2023</a>; <a href="references.html#ref-fishman_gena-lm_2025" role="doc-biblioref">Fishman et al. 2025</a>)</span>.<br>
</li>
<li>Sequence-to-function models (e.g.&nbsp;Enformer, Genomic Interpreter) <span class="citation" data-cites="avsec_enformer_2021 li_genomic_2023">(<a href="references.html#ref-avsec_enformer_2021" role="doc-biblioref">Ž. Avsec et al. 2021</a>; <a href="references.html#ref-li_genomic_2023" role="doc-biblioref">Li et al. 2023</a>)</span>.<br>
</li>
<li>Variant effect predictors (AlphaMissense, GPN-MSA, AlphaGenome, CADD v1.7) <span class="citation" data-cites="rentzsch_cadd_2019 schubach_cadd_2024 cheng_alphamissense_2023 benegas_gpn-msa_2024 avsec_alphagenome_2025">(<a href="references.html#ref-rentzsch_cadd_2019" role="doc-biblioref">Rentzsch et al. 2019</a>; <a href="references.html#ref-schubach_cadd_2024" role="doc-biblioref">Schubach et al. 2024</a>; <a href="references.html#ref-cheng_alphamissense_2023" role="doc-biblioref">Cheng et al. 2023</a>; <a href="references.html#ref-benegas_gpn-msa_2024" role="doc-biblioref">Benegas, Albors, et al. 2024</a>; <a href="references.html#ref-avsec_alphagenome_2025" role="doc-biblioref">Z. Avsec, Latysheva, and Cheng 2025</a>)</span>.</li>
</ul></li>
<li><strong>Feature services</strong>
<ul>
<li>Centralized APIs that take as input variants, genomic intervals, or genes and return embeddings, predicted functional profiles, or risk features.<br>
</li>
<li>Logging and versioning so that analyses can be reproduced even as models and data evolve.</li>
</ul></li>
<li><strong>Data governance</strong>
<ul>
<li>Clear separation between models trained on public data vs.&nbsp;sensitive internal cohorts.<br>
</li>
<li>Guardrails around where internal data can be used for fine-tuning and how resulting models can be shared.</li>
</ul></li>
</ul>
<p>Embedding GFMs in this way allows multiple teams—target ID, biomarker discovery, clinical genetics—to reuse the same core representations rather than each building bespoke models.</p>
</section>
<section id="build-vs-buy-vs-fine-tune" class="level3" data-number="19.5.2">
<h3 data-number="19.5.2" class="anchored" data-anchor-id="build-vs-buy-vs-fine-tune"><span class="header-section-number">19.5.2</span> Build vs buy vs fine-tune</h3>
<p>Organizations face three strategic options:</p>
<ol type="1">
<li><strong>Use external GFMs “as-is”</strong>
<ul>
<li>Pros: Low up-front cost; benefits from community benchmarking (e.g.&nbsp;TraitGym for genotype–phenotype modeling <span class="citation" data-cites="benegas_traitgym_2025">(<a href="references.html#ref-benegas_traitgym_2025" role="doc-biblioref">Benegas, Eraslan, and Song 2025</a>)</span>).<br>
</li>
<li>Cons: May not capture organization-specific populations, assays, or traits.</li>
</ul></li>
<li><strong>Fine-tune open-source GFMs on internal data</strong>
<ul>
<li>Pros: Retains powerful general representations while adapting to local distribution.<br>
</li>
<li>Cons: Requires careful privacy controls and computational investment.</li>
</ul></li>
<li><strong>Train bespoke internal GFMs</strong>
<ul>
<li>Pros: Maximum control; can align pretraining exactly with available data and target use cases.<br>
</li>
<li>Cons: Expensive, complex MLOps; risk of overfitting to narrow datasets if not complemented by broader pretraining.</li>
</ul></li>
</ol>
<p>In practice, many groups adopt a <strong>hybrid strategy</strong>:</p>
<ul>
<li>Start with public GFMs for early exploration and non-sensitive tasks.<br>
</li>
<li>Gradually fine-tune on internal biobank or trial data when added value is clear.<br>
</li>
<li>Maintain lightweight model-serving infrastructure for latency-sensitive applications (e.g.&nbsp;clinical decision support) and heavier offline systems for large-scale research workloads.</li>
</ul>
</section>
<section id="ip-collaboration-and-regulatory-considerations" class="level3" data-number="19.5.3">
<h3 data-number="19.5.3" class="anchored" data-anchor-id="ip-collaboration-and-regulatory-considerations"><span class="header-section-number">19.5.3</span> IP, collaboration, and regulatory considerations</h3>
<p>GFMs also raise new questions around:</p>
<ul>
<li><strong>Intellectual property</strong>
<ul>
<li>Models trained on proprietary data can be valuable IP assets but are hard to patent directly.<br>
</li>
<li>Downstream discoveries (targets, biomarkers) derived from GFMs must be carefully documented for freedom-to-operate.</li>
</ul></li>
<li><strong>Data sharing and federated approaches</strong>
<ul>
<li>Joint training or evaluation across institutions may require federated learning or model-to-data paradigms, especially for patient-level data.</li>
</ul></li>
<li><strong>Regulatory expectations</strong>
<ul>
<li>For biomarkers used in pivotal trials, regulators will expect transparent documentation of model training, validation, and performance across subgroups.<br>
</li>
<li>Chapters 14 and 15 highlight confounding and interpretability challenges that become even more acute when models inform trial inclusion or primary endpoints.</li>
</ul></li>
</ul>
<p>Overall, leveraging GFMs in biotech is as much an <strong>organizational and regulatory engineering problem</strong> as a technical one.</p>
<hr>
</section>
</section>
<section id="forward-look-toward-lab-in-the-loop-gfms" class="level2" data-number="19.6">
<h2 data-number="19.6" class="anchored" data-anchor-id="forward-look-toward-lab-in-the-loop-gfms"><span class="header-section-number">19.6</span> Forward Look: Toward Lab-in-the-Loop GFMs</h2>
<p>A recurring theme across this book is moving from static models to <strong>closed loops</strong> that integrate:</p>
<ol type="1">
<li><strong>Foundational representation learning</strong> on large unlabeled datasets (genomes, multi-omics).<br>
</li>
<li><strong>Task-specific supervision</strong> (disease status, expression, variant effects).<br>
</li>
<li><strong>Experimental feedback</strong> from perturbation assays, functional screens, and clinical trials.</li>
</ol>
<p>In the drug discovery context, this suggests an evolution toward <strong>lab-in-the-loop GFMs</strong>:</p>
<ul>
<li><strong>Hypothesis generation</strong>
<ul>
<li>GFMs identify promising targets, variants, and regulatory regions.<br>
</li>
<li>Graph and set-based models suggest network-level interventions <span class="citation" data-cites="jurenaite_setquence_2024 gao_high-ppi_2023 yuan_linger_2025">(<a href="references.html#ref-jurenaite_setquence_2024" role="doc-biblioref">Jurenaite et al. 2024</a>; <a href="references.html#ref-gao_high-ppi_2023" role="doc-biblioref">Gao et al. 2023</a>; <a href="references.html#ref-yuan_linger_2025" role="doc-biblioref">Yuan and Duren 2025</a>)</span>.</li>
</ul></li>
<li><strong>Experiment design</strong>
<ul>
<li>Models propose perturbation libraries (CRISPR, MPRA) that maximize expected information gain.<br>
</li>
<li>Safety and off-target predictions help filter risky designs.</li>
</ul></li>
<li><strong>Evidence integration and model refinement</strong>
<ul>
<li>Screen results feed back into GFMs, improving their local accuracy in disease-relevant regions of sequence space.<br>
</li>
<li>Clinical trial outcomes update biomarker models and risk predictors for future trials.</li>
</ul></li>
<li><strong>Portfolio-level decision support</strong>
<ul>
<li>Genetic and functional evidence from GFMs is combined with classical pharmacology to prioritize or deprioritize programs.<br>
</li>
<li>Uncertainty estimates and model critique (Chapter 15) help avoid over-confidence in purely model-driven recommendations.</li>
</ul></li>
</ul>
<p>Realizing this vision will require:</p>
<ul>
<li>Better <strong>calibration and uncertainty quantification</strong> in GFMs.<br>
</li>
<li>Stronger <strong>causal reasoning</strong> to distinguish correlation from intervention-worthiness.<br>
</li>
<li>Careful <strong>ethical and equity considerations</strong>, especially when models influence who gets access to trials or targeted therapies (Chapter 14).</li>
</ul>
<p>Yet even in the near term, GFMs already offer tangible value in <strong>de-risking targets, enriching cohorts, and interpreting complex functional data</strong>. When combined with rigorous experimental design and domain expertise, they can act not as oracle decision-makers, but as <strong>force multipliers for human scientists and clinicians</strong>.</p>
<hr>
<p>In summary, this chapter has sketched how genomic foundation models extend beyond academic benchmarks into <strong>practical levers for drug discovery and biotech</strong>:</p>
<ul>
<li>Turning variant and regulatory predictions into <strong>target discovery and validation pipelines</strong>.<br>
</li>
<li>Designing and interpreting <strong>functional genomics screens</strong> that probe mechanism and vulnerability.<br>
</li>
<li>Building richer <strong>biomarkers and patient stratification schemes</strong> for trials.<br>
</li>
<li>Embedding GFMs into <strong>industrial data platforms and MLOps</strong>.</li>
</ul>
<p>Subsequent chapters in Part V can zoom into specific application domains—clinical risk prediction (Chapter 17) and pathogenic variant discovery (Chapter 18)—using the conceptual toolkit laid out here.</p>


<div id="refs" class="references csl-bib-body hanging-indent" data-entry-spacing="0" role="list" style="display: none">
<div id="ref-avsec_enformer_2021" class="csl-entry" role="listitem">
Avsec, Žiga, Vikram Agarwal, D. Visentin, J. Ledsam, A. Grabska-Barwinska, Kyle R. Taylor, Yannis Assael, J. Jumper, Pushmeet Kohli, and David R. Kelley. 2021. <span>“[<span>Enformer</span>] <span>Effective</span> Gene Expression Prediction from Sequence by Integrating Long-Range Interactions.”</span> <em>Nature Methods</em> 18 (October): 1196–1203. <a href="https://doi.org/10.1038/s41592-021-01252-x">https://doi.org/10.1038/s41592-021-01252-x</a>.
</div>
<div id="ref-avsec_alphagenome_2025" class="csl-entry" role="listitem">
Avsec, Ziga, Natasha Latysheva, and Jun Cheng. 2025. <span>“<span>AlphaGenome</span>: <span>AI</span> for Better Understanding the Genome.”</span> <em>Google DeepMind</em>. <a href="https://deepmind.google/discover/blog/alphagenome-ai-for-better-understanding-the-genome/">https://deepmind.google/discover/blog/alphagenome-ai-for-better-understanding-the-genome/</a>.
</div>
<div id="ref-benegas_gpn-msa_2024" class="csl-entry" role="listitem">
Benegas, Gonzalo, Carlos Albors, Alan J. Aw, Chengzhong Ye, and Yun S. Song. 2024. <span>“<span>GPN</span>-<span>MSA</span>: An Alignment-Based <span>DNA</span> Language Model for Genome-Wide Variant Effect Prediction.”</span> <em>bioRxiv</em>, April, 2023.10.10.561776. <a href="https://doi.org/10.1101/2023.10.10.561776">https://doi.org/10.1101/2023.10.10.561776</a>.
</div>
<div id="ref-benegas_traitgym_2025" class="csl-entry" role="listitem">
Benegas, Gonzalo, Gökcen Eraslan, and Yun S. Song. 2025. <span>“[<span>TraitGym</span>] <span>Benchmarking</span> <span>DNA</span> <span>Sequence</span> <span>Models</span> for <span>Causal</span> <span>Regulatory</span> <span>Variant</span> <span>Prediction</span> in <span>Human</span> <span>Genetics</span>.”</span> bioRxiv. <a href="https://doi.org/10.1101/2025.02.11.637758">https://doi.org/10.1101/2025.02.11.637758</a>.
</div>
<div id="ref-benegas_genomic_2024" class="csl-entry" role="listitem">
Benegas, Gonzalo, Chengzhong Ye, Carlos Albors, Jianan Canal Li, and Yun S. Song. 2024. <span>“Genomic <span>Language</span> <span>Models</span>: <span>Opportunities</span> and <span>Challenges</span>.”</span> arXiv. <a href="https://doi.org/10.48550/arXiv.2407.11435">https://doi.org/10.48550/arXiv.2407.11435</a>.
</div>
<div id="ref-brandes_genome-wide_2023" class="csl-entry" role="listitem">
Brandes, Nadav, Grant Goldman, Charlotte H. Wang, Chun Jimmie Ye, and Vasilis Ntranos. 2023. <span>“Genome-Wide Prediction of Disease Variant Effects with a Deep Protein Language Model.”</span> <em>Nature Genetics</em> 55 (9): 1512–22. <a href="https://doi.org/10.1038/s41588-023-01465-0">https://doi.org/10.1038/s41588-023-01465-0</a>.
</div>
<div id="ref-cheng_alphamissense_2023" class="csl-entry" role="listitem">
Cheng, Jun, Guido Novati, Joshua Pan, Clare Bycroft, Akvilė Žemgulytė, Taylor Applebaum, Alexander Pritzel, et al. 2023. <span>“[<span>AlphaMissense</span>] <span>Accurate</span> Proteome-Wide Missense Variant Effect Prediction with <span>AlphaMissense</span>.”</span> <em>Science</em> 381 (6664): eadg7492. <a href="https://doi.org/10.1126/science.adg7492">https://doi.org/10.1126/science.adg7492</a>.
</div>
<div id="ref-dalla-torre_nucleotide_2023" class="csl-entry" role="listitem">
Dalla-Torre, Hugo, Liam Gonzalez, Javier Mendoza-Revilla, Nicolas Lopez Carranza, Adam Henryk Grzywaczewski, Francesco Oteri, Christian Dallago, et al. 2023. <span>“Nucleotide <span>Transformer</span>: Building and Evaluating Robust Foundation Models for Human Genomics.”</span> <em>Nature Methods</em> 22 (2): 287–97. <a href="https://doi.org/10.1038/s41592-024-02523-z">https://doi.org/10.1038/s41592-024-02523-z</a>.
</div>
<div id="ref-fishman_gena-lm_2025" class="csl-entry" role="listitem">
Fishman, Veniamin, Yuri Kuratov, Aleksei Shmelev, Maxim Petrov, Dmitry Penzar, Denis Shepelin, Nikolay Chekanov, Olga Kardymon, and Mikhail Burtsev. 2025. <span>“<span>GENA</span>-<span>LM</span>: A Family of Open-Source Foundational <span>DNA</span> Language Models for Long Sequences.”</span> <em>Nucleic Acids Research</em> 53 (2): gkae1310. <a href="https://doi.org/10.1093/nar/gkae1310">https://doi.org/10.1093/nar/gkae1310</a>.
</div>
<div id="ref-gao_high-ppi_2023" class="csl-entry" role="listitem">
Gao, Ziqi, Chenran Jiang, Jiawen Zhang, Xiaosen Jiang, Lanqing Li, Peilin Zhao, Huanming Yang, Yong Huang, and Jia Li. 2023. <span>“[<span>HIGH</span>-<span>PPI</span>] <span>Hierarchical</span> Graph Learning for Protein–Protein Interaction.”</span> <em>Nature Communications</em> 14 (1): 1093. <a href="https://doi.org/10.1038/s41467-023-36736-1">https://doi.org/10.1038/s41467-023-36736-1</a>.
</div>
<div id="ref-georgantas_delphi_2024" class="csl-entry" role="listitem">
Georgantas, Costa, Zoltán Kutalik, and Jonas Richiardi. 2024. <span>“Delphi: <span>A</span> <span>Deep</span>-Learning <span>Method</span> for <span>Polygenic</span> <span>Risk</span> <span>Prediction</span>.”</span> medRxiv. <a href="https://doi.org/10.1101/2024.04.19.24306079">https://doi.org/10.1101/2024.04.19.24306079</a>.
</div>
<div id="ref-he_nucleic_2023" class="csl-entry" role="listitem">
He, Shujun, Baizhen Gao, Rushant Sabnis, and Qing Sun. 2023. <span>“Nucleic <span>Transformer</span>: <span>Classifying</span> <span>DNA</span> <span>Sequences</span> with <span>Self</span>-<span>Attention</span> and <span>Convolutions</span>.”</span> <em>ACS Synthetic Biology</em> 12 (11): 3205–14. <a href="https://doi.org/10.1021/acssynbio.3c00154">https://doi.org/10.1021/acssynbio.3c00154</a>.
</div>
<div id="ref-jurenaite_setquence_2024" class="csl-entry" role="listitem">
Jurenaite, Neringa, Daniel León-Periñán, Veronika Donath, Sunna Torge, and René Jäkel. 2024. <span>“<span>SetQuence</span> &amp; <span>SetOmic</span>: <span>Deep</span> Set Transformers for Whole Genome and Exome Tumour Analysis.”</span> <em>BioSystems</em> 235 (January): 105095. <a href="https://doi.org/10.1016/j.biosystems.2023.105095">https://doi.org/10.1016/j.biosystems.2023.105095</a>.
</div>
<div id="ref-li_genomic_2023" class="csl-entry" role="listitem">
Li, Zehui, Akashaditya Das, William A. V. Beardall, Yiren Zhao, and Guy-Bart Stan. 2023. <span>“Genomic <span>Interpreter</span>: <span>A</span> <span>Hierarchical</span> <span>Genomic</span> <span>Deep</span> <span>Neural</span> <span>Network</span> with <span>1D</span> <span>Shifted</span> <span>Window</span> <span>Transformer</span>.”</span> arXiv. <a href="https://doi.org/10.48550/arXiv.2306.05143">https://doi.org/10.48550/arXiv.2306.05143</a>.
</div>
<div id="ref-marquet_vespag_2024" class="csl-entry" role="listitem">
Marquet, Céline, Julius Schlensok, Marina Abakarova, Burkhard Rost, and Elodie Laine. 2024. <span>“[<span>VespaG</span>] <span>Expert</span>-Guided Protein Language Models Enable Accurate and Blazingly Fast Fitness Prediction.”</span> <em>Bioinformatics</em> 40 (11): btae621. <a href="https://doi.org/10.1093/bioinformatics/btae621">https://doi.org/10.1093/bioinformatics/btae621</a>.
</div>
<div id="ref-nguyen_hyenadna_2023" class="csl-entry" role="listitem">
Nguyen, Eric, Michael Poli, Marjan Faizi, Armin Thomas, Callum Birch-Sykes, Michael Wornow, Aman Patel, et al. 2023. <span>“<span>HyenaDNA</span>: <span>Long</span>-<span>Range</span> <span>Genomic</span> <span>Sequence</span> <span>Modeling</span> at <span>Single</span> <span>Nucleotide</span> <span>Resolution</span>.”</span> arXiv. <a href="https://doi.org/10.48550/arXiv.2306.15794">https://doi.org/10.48550/arXiv.2306.15794</a>.
</div>
<div id="ref-rakowski_mifm_2025" class="csl-entry" role="listitem">
Rakowski, Alexander, and Christoph Lippert. 2025. <span>“[<span>MIFM</span>] <span>Multiple</span> Instance Fine-Mapping: Predicting Causal Regulatory Variants with a Deep Sequence Model.”</span> medRxiv. <a href="https://doi.org/10.1101/2025.06.13.25329551">https://doi.org/10.1101/2025.06.13.25329551</a>.
</div>
<div id="ref-rentzsch_cadd_2019" class="csl-entry" role="listitem">
Rentzsch, Philipp, Daniela Witten, Gregory M Cooper, Jay Shendure, and Martin Kircher. 2019. <span>“<span>CADD</span>: Predicting the Deleteriousness of Variants Throughout the Human Genome.”</span> <em>Nucleic Acids Research</em> 47 (D1): D886–94. <a href="https://doi.org/10.1093/nar/gky1016">https://doi.org/10.1093/nar/gky1016</a>.
</div>
<div id="ref-schubach_cadd_2024" class="csl-entry" role="listitem">
Schubach, Max, Thorben Maass, Lusiné Nazaretyan, Sebastian Röner, and Martin Kircher. 2024. <span>“<span>CADD</span> V1.7: Using Protein Language Models, Regulatory <span>CNNs</span> and Other Nucleotide-Level Scores to Improve Genome-Wide Variant Predictions.”</span> <em>Nucleic Acids Research</em> 52 (D1): D1143–54. <a href="https://doi.org/10.1093/nar/gkad989">https://doi.org/10.1093/nar/gkad989</a>.
</div>
<div id="ref-trop_genomics_2024" class="csl-entry" role="listitem">
Trop, Evan, Yair Schiff, Edgar Mariano Marroquin, Chia Hsiang Kao, Aaron Gokaslan, McKinley Polen, Mingyi Shao, et al. 2024. <span>“The <span>Genomics</span> <span>Long</span>-<span>Range</span> <span>Benchmark</span>: <span>Advancing</span> <span>DNA</span> <span>Language</span> <span>Models</span>,”</span> October. <a href="https://openreview.net/forum?id=8O9HLDrmtq">https://openreview.net/forum?id=8O9HLDrmtq</a>.
</div>
<div id="ref-wu_genome-wide_2024" class="csl-entry" role="listitem">
Wu, Yang, Zhili Zheng, Loic Thibaut2, Michael E. Goddard, Naomi R. Wray, Peter M. Visscher, and Jian Zeng. 2024. <span>“Genome-Wide Fine-Mapping Improves Identification of Causal Variants.”</span> <em>Research Square</em>, August, rs.3.rs–4759390. <a href="https://doi.org/10.21203/rs.3.rs-4759390/v1">https://doi.org/10.21203/rs.3.rs-4759390/v1</a>.
</div>
<div id="ref-yan_recent_2025" class="csl-entry" role="listitem">
Yan, Binghao, Yunbi Nam, Lingyao Li, Rebecca A. Deek, Hongzhe Li, and Siyuan Ma. 2025. <span>“Recent Advances in Deep Learning and Language Models for Studying the Microbiome.”</span> <em>Frontiers in Genetics</em> 15 (January). <a href="https://doi.org/10.3389/fgene.2024.1494474">https://doi.org/10.3389/fgene.2024.1494474</a>.
</div>
<div id="ref-yuan_linger_2025" class="csl-entry" role="listitem">
Yuan, Qiuyue, and Zhana Duren. 2025. <span>“[<span>LINGER</span>] <span>Inferring</span> Gene Regulatory Networks from Single-Cell Multiome Data Using Atlas-Scale External Data.”</span> <em>Nature Biotechnology</em> 43 (2): 247–57. <a href="https://doi.org/10.1038/s41587-024-02182-7">https://doi.org/10.1038/s41587-024-02182-7</a>.
</div>
<div id="ref-zhou_deepsea_2015" class="csl-entry" role="listitem">
Zhou, Jian, and Olga G. Troyanskaya. 2015. <span>“[<span>DeepSEA</span>] <span>Predicting</span> Effects of Noncoding Variants with Deep Learning–Based Sequence Model.”</span> <em>Nature Methods</em> 12 (10): 931–34. <a href="https://doi.org/10.1038/nmeth.3547">https://doi.org/10.1038/nmeth.3547</a>.
</div>
</div>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
  window.document.addEventListener("DOMContentLoaded", function (event) {
    const icon = "";
    const anchorJS = new window.AnchorJS();
    anchorJS.options = {
      placement: 'right',
      icon: icon
    };
    anchorJS.add('.anchored');
    const isCodeAnnotation = (el) => {
      for (const clz of el.classList) {
        if (clz.startsWith('code-annotation-')) {                     
          return true;
        }
      }
      return false;
    }
    const onCopySuccess = function(e) {
      // button target
      const button = e.trigger;
      // don't keep focus
      button.blur();
      // flash "checked"
      button.classList.add('code-copy-button-checked');
      var currentTitle = button.getAttribute("title");
      button.setAttribute("title", "Copied!");
      let tooltip;
      if (window.bootstrap) {
        button.setAttribute("data-bs-toggle", "tooltip");
        button.setAttribute("data-bs-placement", "left");
        button.setAttribute("data-bs-title", "Copied!");
        tooltip = new bootstrap.Tooltip(button, 
          { trigger: "manual", 
            customClass: "code-copy-button-tooltip",
            offset: [0, -8]});
        tooltip.show();    
      }
      setTimeout(function() {
        if (tooltip) {
          tooltip.hide();
          button.removeAttribute("data-bs-title");
          button.removeAttribute("data-bs-toggle");
          button.removeAttribute("data-bs-placement");
        }
        button.setAttribute("title", currentTitle);
        button.classList.remove('code-copy-button-checked');
      }, 1000);
      // clear code selection
      e.clearSelection();
    }
    const getTextToCopy = function(trigger) {
      const outerScaffold = trigger.parentElement.cloneNode(true);
      const codeEl = outerScaffold.querySelector('code');
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
    const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
      text: getTextToCopy
    });
    clipboard.on('success', onCopySuccess);
    if (window.document.getElementById('quarto-embedded-source-code-modal')) {
      const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
        text: getTextToCopy,
        container: window.document.getElementById('quarto-embedded-source-code-modal')
      });
      clipboardModal.on('success', onCopySuccess);
    }
      var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
      var mailtoRegex = new RegExp(/^mailto:/);
        var filterRegex = new RegExp('/' + window.location.host + '/');
      var isInternal = (href) => {
          return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
      }
      // Inspect non-navigation links and adorn them if external
     var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
      for (var i=0; i<links.length; i++) {
        const link = links[i];
        if (!isInternal(link.href)) {
          // undo the damage that might have been done by quarto-nav.js in the case of
          // links that we want to consider external
          if (link.dataset.originalHref !== undefined) {
            link.href = link.dataset.originalHref;
          }
        }
      }
    function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
      const config = {
        allowHTML: true,
        maxWidth: 500,
        delay: 100,
        arrow: false,
        appendTo: function(el) {
            return el.parentElement;
        },
        interactive: true,
        interactiveBorder: 10,
        theme: 'quarto',
        placement: 'bottom-start',
      };
      if (contentFn) {
        config.content = contentFn;
      }
      if (onTriggerFn) {
        config.onTrigger = onTriggerFn;
      }
      if (onUntriggerFn) {
        config.onUntrigger = onUntriggerFn;
      }
      window.tippy(el, config); 
    }
    const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
    for (var i=0; i<noterefs.length; i++) {
      const ref = noterefs[i];
      tippyHover(ref, function() {
        // use id or data attribute instead here
        let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
        try { href = new URL(href).hash; } catch {}
        const id = href.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note) {
          return note.innerHTML;
        } else {
          return "";
        }
      });
    }
    const xrefs = window.document.querySelectorAll('a.quarto-xref');
    const processXRef = (id, note) => {
      // Strip column container classes
      const stripColumnClz = (el) => {
        el.classList.remove("page-full", "page-columns");
        if (el.children) {
          for (const child of el.children) {
            stripColumnClz(child);
          }
        }
      }
      stripColumnClz(note)
      if (id === null || id.startsWith('sec-')) {
        // Special case sections, only their first couple elements
        const container = document.createElement("div");
        if (note.children && note.children.length > 2) {
          container.appendChild(note.children[0].cloneNode(true));
          for (let i = 1; i < note.children.length; i++) {
            const child = note.children[i];
            if (child.tagName === "P" && child.innerText === "") {
              continue;
            } else {
              container.appendChild(child.cloneNode(true));
              break;
            }
          }
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(container);
          }
          return container.innerHTML
        } else {
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(note);
          }
          return note.innerHTML;
        }
      } else {
        // Remove any anchor links if they are present
        const anchorLink = note.querySelector('a.anchorjs-link');
        if (anchorLink) {
          anchorLink.remove();
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        if (note.classList.contains("callout")) {
          return note.outerHTML;
        } else {
          return note.innerHTML;
        }
      }
    }
    for (var i=0; i<xrefs.length; i++) {
      const xref = xrefs[i];
      tippyHover(xref, undefined, function(instance) {
        instance.disable();
        let url = xref.getAttribute('href');
        let hash = undefined; 
        if (url.startsWith('#')) {
          hash = url;
        } else {
          try { hash = new URL(url).hash; } catch {}
        }
        if (hash) {
          const id = hash.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note !== null) {
            try {
              const html = processXRef(id, note.cloneNode(true));
              instance.setContent(html);
            } finally {
              instance.enable();
              instance.show();
            }
          } else {
            // See if we can fetch this
            fetch(url.split('#')[0])
            .then(res => res.text())
            .then(html => {
              const parser = new DOMParser();
              const htmlDoc = parser.parseFromString(html, "text/html");
              const note = htmlDoc.getElementById(id);
              if (note !== null) {
                const html = processXRef(id, note);
                instance.setContent(html);
              } 
            }).finally(() => {
              instance.enable();
              instance.show();
            });
          }
        } else {
          // See if we can fetch a full url (with no hash to target)
          // This is a special case and we should probably do some content thinning / targeting
          fetch(url)
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.querySelector('main.content');
            if (note !== null) {
              // This should only happen for chapter cross references
              // (since there is no id in the URL)
              // remove the first header
              if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
                note.children[0].remove();
              }
              const html = processXRef(null, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      }, function(instance) {
      });
    }
        let selectedAnnoteEl;
        const selectorForAnnotation = ( cell, annotation) => {
          let cellAttr = 'data-code-cell="' + cell + '"';
          let lineAttr = 'data-code-annotation="' +  annotation + '"';
          const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
          return selector;
        }
        const selectCodeLines = (annoteEl) => {
          const doc = window.document;
          const targetCell = annoteEl.getAttribute("data-target-cell");
          const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
          const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
          const lines = annoteSpan.getAttribute("data-code-lines").split(",");
          const lineIds = lines.map((line) => {
            return targetCell + "-" + line;
          })
          let top = null;
          let height = null;
          let parent = null;
          if (lineIds.length > 0) {
              //compute the position of the single el (top and bottom and make a div)
              const el = window.document.getElementById(lineIds[0]);
              top = el.offsetTop;
              height = el.offsetHeight;
              parent = el.parentElement.parentElement;
            if (lineIds.length > 1) {
              const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
              const bottom = lastEl.offsetTop + lastEl.offsetHeight;
              height = bottom - top;
            }
            if (top !== null && height !== null && parent !== null) {
              // cook up a div (if necessary) and position it 
              let div = window.document.getElementById("code-annotation-line-highlight");
              if (div === null) {
                div = window.document.createElement("div");
                div.setAttribute("id", "code-annotation-line-highlight");
                div.style.position = 'absolute';
                parent.appendChild(div);
              }
              div.style.top = top - 2 + "px";
              div.style.height = height + 4 + "px";
              div.style.left = 0;
              let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
              if (gutterDiv === null) {
                gutterDiv = window.document.createElement("div");
                gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
                gutterDiv.style.position = 'absolute';
                const codeCell = window.document.getElementById(targetCell);
                const gutter = codeCell.querySelector('.code-annotation-gutter');
                gutter.appendChild(gutterDiv);
              }
              gutterDiv.style.top = top - 2 + "px";
              gutterDiv.style.height = height + 4 + "px";
            }
            selectedAnnoteEl = annoteEl;
          }
        };
        const unselectCodeLines = () => {
          const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
          elementsIds.forEach((elId) => {
            const div = window.document.getElementById(elId);
            if (div) {
              div.remove();
            }
          });
          selectedAnnoteEl = undefined;
        };
          // Handle positioning of the toggle
      window.addEventListener(
        "resize",
        throttle(() => {
          elRect = undefined;
          if (selectedAnnoteEl) {
            selectCodeLines(selectedAnnoteEl);
          }
        }, 10)
      );
      function throttle(fn, ms) {
      let throttle = false;
      let timer;
        return (...args) => {
          if(!throttle) { // first call gets through
              fn.apply(this, args);
              throttle = true;
          } else { // all the others get throttled
              if(timer) clearTimeout(timer); // cancel #2
              timer = setTimeout(() => {
                fn.apply(this, args);
                timer = throttle = false;
              }, ms);
          }
        };
      }
        // Attach click handler to the DT
        const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
        for (const annoteDlNode of annoteDls) {
          annoteDlNode.addEventListener('click', (event) => {
            const clickedEl = event.target;
            if (clickedEl !== selectedAnnoteEl) {
              unselectCodeLines();
              const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
              if (activeEl) {
                activeEl.classList.remove('code-annotation-active');
              }
              selectCodeLines(clickedEl);
              clickedEl.classList.add('code-annotation-active');
            } else {
              // Unselect the line
              unselectCodeLines();
              clickedEl.classList.remove('code-annotation-active');
            }
          });
        }
    const findCites = (el) => {
      const parentEl = el.parentElement;
      if (parentEl) {
        const cites = parentEl.dataset.cites;
        if (cites) {
          return {
            el,
            cites: cites.split(' ')
          };
        } else {
          return findCites(el.parentElement)
        }
      } else {
        return undefined;
      }
    };
    var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
    for (var i=0; i<bibliorefs.length; i++) {
      const ref = bibliorefs[i];
      const citeInfo = findCites(ref);
      if (citeInfo) {
        tippyHover(citeInfo.el, function() {
          var popup = window.document.createElement('div');
          citeInfo.cites.forEach(function(cite) {
            var citeDiv = window.document.createElement('div');
            citeDiv.classList.add('hanging-indent');
            citeDiv.classList.add('csl-entry');
            var biblioDiv = window.document.getElementById('ref-' + cite);
            if (biblioDiv) {
              citeDiv.innerHTML = biblioDiv.innerHTML;
            }
            popup.appendChild(citeDiv);
          });
          return popup.innerHTML;
        });
      }
    }
  });
  </script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="./ch-p5-variants.html" class="pagination-link" aria-label="Pathogenic Variant Discovery">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">18</span>&nbsp; <span class="chapter-title">Pathogenic Variant Discovery</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./references.html" class="pagination-link" aria-label="References">
        <span class="nav-page-text">References</span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->
<footer class="footer">
  <div class="nav-footer">
    <div class="nav-footer-left">
      &nbsp;
    </div>   
    <div class="nav-footer-center">
<p>Copyright 2025, Josh Meehl</p>
</div>
    <div class="nav-footer-right">
      &nbsp;
    </div>
  </div>
</footer>




</body></html>